These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14 related articles for article (PubMed ID: 3453428)
1. [Disagreement in standardized haloperidol treatment in comparison with "adequate individual dosage" of acutely schizophrenic patients]. Klieser E; Lehmann E Fortschr Neurol Psychiatr; 1992 Mar; 60(3):126-9. PubMed ID: 1577361 [TBL] [Abstract][Full Text] [Related]
2. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients]. Klieser E; Lehmann E; Tegeler J Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333 [TBL] [Abstract][Full Text] [Related]
3. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol. den Boer JA; Westenberg HG Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol. Hwang TJ; Lin SK; Lin HN J Formos Med Assoc; 2001 Dec; 100(12):811-6. PubMed ID: 11802520 [TBL] [Abstract][Full Text] [Related]
5. A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients. Bechelli LP; Ruffino-Netto A; Hetem G Braz J Med Biol Res; 1983 Dec; 16(4):305-11. PubMed ID: 6143579 [TBL] [Abstract][Full Text] [Related]
6. Experimental comparison of the effectivity of individually adapted and standardized dosages of haloperidol. Klieser E; Lehmann E Neuropsychobiology; 1987; 18(3):122-6. PubMed ID: 3453428 [TBL] [Abstract][Full Text] [Related]